Efficient and accurate mRNA biogenesis is achieved by coupling synthesis of the transcript by Pol II with RNA processing by capping, splicing and cleavage and polyadenylation. The coupling of pre-mRNA processing with transcription is thought to occur by the association of processing factors with the transcription elongation complex (TEC), largely through protein-protein interactions with the C-terminal heptad repeat domain (CTD) of the Pol II large subunit. The CTD enhances splicing and 3′ end processing and is thought to act as a landing pad for processing factors during transcription 1-3 . The CTD also helps to coordinate splicing with RNA editing 4 in a process that requires intramolecular base pairing often between exon and intron sequences. These various co-transcriptional functions of the CTD presumably require that the nascent transcript remains in close proximity to the RNA polymerase.
is defined by interactions of U2 snRNP and U2AF with cleavage and polyadenylation factors and Pol II [31] [32] [33] . Ribozyme cleavage of β-globin exon 2 disrupted splicing of intron 1, but, unexpectedly, splicing of intron 2 was unaffected 21 . The inhibition of splicing by exon cutting suggests that exon definition operates in vivo in mammalian cells. However, it is not known whether exon cutting affects splicing under conditions when exon definition does not occur, nor is it known how ribozyme cleavage within the first and last exons affects splicing.
Other experiments using similar RNA-cutting strategies are not readily reconciled with exon tethering. We and others reported that poly(A) site cleavage and splicing of the last intron are disrupted by severing the nascent RNA downstream of the poly(A) site, either by a ribozyme in vivo 34 or by RNAse H digestion in vitro 20, 33 . This effect is most easily explained if cutting the RNA disrupts its association with Pol II and CTD-associated processing factors. Unexpectedly, although ribozyme cutting close to the poly(A) site interferes with processing, it was reported not to inhibit transcription termination 26 , in an apparent exception to tight coupling of termination with 3′ end processing 35 .
We reexamined the question of transcript tethering to the TEC in vivo by severing the nascent RNA within exons or introns using selfcleaving hepatitis δ or hammerhead ribozymes. Our results suggest that splicing is facilitated by a link with Pol II that can be disrupted by a ribozyme situated in either an exon or an intron, provided that RNA cleavage is fast enough to compete with splicing. These results therefore argue against exon tethering and suggest that, in response to endonucleolytic damage inflicted on a nascent transcript, splicing and 3′ end processing can be aborted.
RESULTS

Decapitation by ribozyme cleavage in exon 1 inhibits splicing
To investigate the effects of severing the RNA connection between CBC and the rest of the transcription complex, we incorporated the hepatitis δ variant ribozyme or an inactive point mutant 34 into exon 1 of a CMV β-globin reporter gene 63 nucleotides (nt) from the cap. A histone stem-loop sequence was included upstream of the ribozyme cut site to stabilize the 5′ product 36 . We analyzed transcripts made in transiently transfected cells using an RNAse protection assay (RPA) that permits quantification of processed and unprocessed transcripts. RPA with a probe spanning the ribozyme cut site showed complete cleavage by the wild-type but not the mutant ribozyme (Fig. 1a) . The 3′ products of ribozyme cleavage, which lack a cap, were relatively stable (data not shown), presumably because the 5′ OH and secondary structure of the ribozyme are poor substrates for 5′ exonucleases.
As expected, removal of the cap by the wild-type ribozyme in exon 1 markedly reduced the steady-state ratio of spliced/unspliced intron 1 transcripts, consistent with inhibition of splicing, relative to the mutant ribozyme control ( Fig. 1b, lanes 1-3) . More unexpectedly, severing exon 1 also inhibited intron 2 splicing and poly(A) site cleavage ( Fig. 1b , lanes 4-6 and Supplementary Fig. 1a ). The magnitude of the splicing defects caused by ribozyme cutting in our experiments would be underestimated if unspliced precursors are less stable than spliced RNAs. This possibility is suggested by the fact that ribozyme cleavage in exon 1 (Fig. 1b) and elsewhere (see below) reduced the accumulation of spliced RNA without an equivalent increase of unspliced precursors (Fig. 1b) . This apparent instability of unspliced transcripts was reversed by mutation of the poly(A) site ( Fig. 1c) , as discussed below. Inhibition of nonsense-mediated decay (NMD) or the exosome by dominant-negative Upf1 or PM-Scl-75 short hairpin RNAs (shRNAs) did not affect the ratio of spliced/unspliced transcripts (data not shown), arguing against the unlikely possibility that spliced transcripts are preferentially degraded following ribozyme cleavage. In summary, the experiments in Figure 1 suggest that a continuous RNA connection between the cap and the rest of the transcript enhances all steps in processing of the β-globin pre-mRNA, not just splicing of the first intron.
Severing exon 2 inhibits processing upstream and downstream
We next examined the effects of cutting the β-globin transcript in exon 2. The hepatitis δ ribozyme inserted in exon 2, 119 nt upstream of the 5′ splice site, strongly reduced the ratio of spliced/unspliced transcripts of intron 1 (Supplementary Fig. 1b, lanes 1-3) , as previously reported for the hammerhead 21 . Unexpectedly, δ ribozyme cutting in exon 2 also impaired splicing of intron 2 and poly(A) site cleavage (Supplementary Fig. 1b , lanes 4-9), consistent with the idea that an intact 5′ end is important for these downstream processing events. We note, however, that in the context of a stably integrated chromosomal β-globin reporter gene, ribozyme cutting in exon 2 inhibited intron 1 splicing ( Supplementary Fig. 2a ) but had little effect on 3′ end processing (data not shown). This discrepancy may reflect a change in the kinetics of co-transcriptional processing, transcription elongation or pausing in a chromosomal context relative to a transiently transfected plasmid.
It is possible that inhibition of intron 1 splicing by severing exon 2 is caused by disruption of interactions with the poly(A) site, which stimulates splicing of both introns 10 . We therefore asked how cutting exon 2 affects splicing of transcripts with a mutant poly(A) site (A2GA3) and a fibronectin splicing enhancer (FN) inserted in exon 3 (Fig. 1c) . Splicing of introns 1 and 2 was inhibited by the wild-type but not the mutant ribozyme in exon 2 (Fig. 1c) . (c) RPA of intron 1 and intron 2 splicing in exon 2 ribozyme constructs with a mutant poly(A) site (A2GA3) and fibronectin splicing enhancer (FN) in exon 3 ( Supplementary Table 1 , plasmids 6 and 7). The maps depict antisense RPA probes (black arrows), the wild-type or mutant ribozymes (vertical gray arrows), the FN, the poly(A) site (downward black arrows) and the poly(A) site mutation (AAGAAA).
a r t i c l e s a r t i c l e s
The shutdown of splicing caused by severing exon 2 is therefore independent of a functional poly(A) site.
In constructs with the A2GA3 mutant poly(A) site, ribozyme cleavage always elevated the level of unspliced precursors relative to the VA loading control (a short noncoding RNA from adenovirus) ( Fig. 1c) . This apparent stabilization of unspliced transcripts may be due to their retention at the site of transcription 34 . In summary, ribozyme cutting in exons 1 and 2 causes a general shutdown of splicing and 3′ end processing of β-globin transcripts (Figure 1 and Supplementary Figure 1 ).
Transcript release by ribozyme cutting
To test whether the transcript is tethered at the gene following ribozyme cleavage in exon 2, we monitored the CBC, which binds the 5′ ends of nascent transcripts, by chromatin immunoprecipitation (ChIP) with anti-CBP80 antibody. If exon 1 is tethered, then the CBC ChIP signal should be unaffected by the ribozyme. Conversely, if the RNA is released by the ribozyme, then the CBC ChIP signal should diminish at positions downstream of the cut. We analyzed Pol II and CBP80 by ChIP at 12 amplicons along the β-globin gene with the wild-type or mutant hepatitis δ ribozyme in exon 2. Because high-resolution ChIP was not possible with plasmids, we integrated a single copy of the CMV driven, tet-inducible β-globin genes by sitespecific recombination. As expected, intron 1 splicing was inhibited by the wild-type but not the mutant ribozyme in these cell lines ( Supplementary Fig. 2a ). The distribution of Pol II on β-globin was not detectably affected by ribozyme cutting in exon 2 ( Fig. 2a) . In contrast, CBP80 cross-linking was specifically reduced in the vicinity of the wild-type δ ribozyme and at positions downstream compared to the mutant control (Fig. 2b) . The effect of the ribozyme on CBP80 ChIP signals was a reduction of only about two-fold at most positions, possibly because not all transcripts are co-transcriptionally cleaved before polymerase reaches the end of the gene. The fact that a wildtype ribozyme reproducibly reduces the CBP80 ChIP signal relative to the mutant strongly suggests that nascent RNA with CBC bound to the 5′ cap is released from the gene. In summary, these results argue that, rather than being tethered to the template, exon 1 is released by RNA cleavage in exon 2.
Intronic hepatitis  but not hammerhead ribozyme inhibits splicing
We next addressed whether splicing can occur across a cut within an intron by introducing the hepatitis δ ribozyme into intron 2, positioning it 200 nt from the 5′ splice site. The wild-type ribozyme consistently inhibited splicing of intron 2, whereas the mutant ribozyme had no effect ( Fig. 3a , lanes 1, 4 and 5). A similar inhibition of splicing was caused by the wild-type δ ribozyme in intron 2 of a β-globin gene with a poly(A) site mutation and fibronectin splicing enhancer (FNA2GA3) (Fig. 3a , lanes 11 and 12). To control for the possibility that the spliced/unspliced ratio is biased by selective degradation in the cytoplasm, we analyzed fractionated nuclear and cytoplasmic RNA. The reduction of spliced/unspliced transcripts caused by intronic δ ribozyme is reproduced in nuclear RNA (Fig. 3a,  lanes 13 and 15) .
The inhibition of splicing by the δ ribozyme in intron 2 contrasts with previous observations using the minimal hammerhead ribozyme 21 , so we compared splicing with the two ribozymes at the same position in intron 2. Compared to the δ ribozyme, the wild-type hammerhead caused a much smaller inhibition of splicing ( Fig. 3a,  lanes 1-3) . The hammerhead and hepatitis δ ribozymes in intron 2 cut with approximately equivalent efficiencies, as monitored by RPA with probes spanning the ribozyme cut sites (Fig. 3b) . Therefore, the different effects of these two ribozymes on intron 2 splicing cannot be explained by differential cutting. Furthermore, the 5′ and 3′ ends made by the hammerhead and hepatitis δ ribozymes were discrete and accumulated to approximately equivalent levels, indicating that they are not rapidly degraded. Because both ribozymes generate RNA fragments with identical end structures, the specific reduction in the ratio of spliced/unspliced transcripts caused by the δ ribozyme cannot be explained by differential degradation of spliced versus unspliced RNA in response to ribozyme-generated 5′ and 3′ ends. To account for the different effects of the two intronic ribozymes, we propose that, because the hepatitis δ ribozyme cuts far more rapidly than the hammerhead ribozyme 37, 38 , it can compete effectively with spliceosome assembly. We also tested whether precursors for miR21 or miR30 (ref. 39 ) affected splicing when inserted into intron 2 of constructs with the A2GA3 mutant poly(A) site to enhance their processing 40 . Consistent with previous findings 23, 24 , the miRNA precursors had little or no effect on intron 2 splicing ( Supplementary  Fig. 2b) suggesting that, like the hammerhead, cleavage by Drosha is relatively slow and does not compete with splicing.
Previous investigations of ribozyme cleavage in intron 2 (ref. 21 ) were performed with a reporter gene activated by HIV1 Tat, which could facilitate tethering because it binds RNA and Pol II. We therefore asked how the δ ribozyme in intron 2 affected splicing of transcripts driven by the Tat-activated HIV1 long terminal repeat (LTR) compared to the CMV promoter. Intron 2 splicing was inhibited by the wild-type Supplementary Table 3) .
Mean values are normalized to the maximal signal at the β-globin amplicon +80; the s.e.m. is shown.
Results are from two independent cells lines for the wild-type and mutant ribozyme constructs. Note that ribozyme cutting has no effect on Pol II distribution (a) but specifically reduces CBP80 levels within the gene (amplicons +370 to +4824) relative to the 5′ end (amplicons +30, +80) (b). The map shows PCR amplicon positions relative to the CMV start site, Tet operators (gray box) and δ ribozyme (vertical gray arrow).
a r t i c l e s δ ribozyme relative to the mutant regardless of the promoter (Fig. 3a,  compare lanes 4 and 5 with lanes 9 and 10) . The hammerhead had a small inhibitory effect on splicing with both promoters (lanes 2, 3, 7 and 8). We conclude that inhibition of splicing by cutting an intron is not promoter specific. Although ribozyme cleavage in intron 2 is not expected to affect definition of exon 2, we consistently observed that splicing of intron 1 was inhibited (Fig. 4a, lanes 1-3) but to a smaller extent than splicing of intron 2 (Fig. 3a) . Cutting intron 2 with the δ ribozyme, but not the hammerhead ribozyme, also inhibited 3′ processing of CMV-and HIV1-driven transcripts (Fig. 4a, lanes 5  and 7, and Supplementary Fig. 3, lanes 2 and 4) .
To ask how ribozyme cleavage of intron 2 affected protein expression, we monitored accumulation of the hemagglutinin (HA)-tagged globin protein. The intronic δ ribozyme abolished protein expression relative to the co-transfected GFP control (Fig. 4b, lane 2) , whereas the hammerhead ribozyme had little or no effect (Fig. 4b, lane 4) . The protein expression data are therefore consistent with the RNA analysis demonstrating that cutting intron 2 ( Figs. 3 and 4a) shuts down splicing and 3′ end processing.
Intron cutting inhibits ADAR-mediated RNA editing
We also examined the effects of ribozyme cleavage in an intron of the glutamate receptor subunit B (GluR-B) gene 4 at a site in between the glutamine-arginine (Q/R) editing site in exon 11 and the complementary sequence in intron 11 that directs adenosine to inosine (A-I) editing by ADAR (adenosine deaminase acting on RNA) enzymes. If ribozyme cutting results in physical separation of the upstream and downstream RNA fragments, it should disrupt editing. Conversely, if the exons are tethered to the TEC, then ribozyme cutting should not impede the base pairing that enables editing. cDNA sequencing showed that editing of the Q/R site from A to G was inhibited by the wild-type ribozyme in intron 11, relative to the mutant (Fig. 4c, left) . We suggest that severing the intron impairs editing by preventing base pairing between the Q/R site upstream of the cut and the complementary sequence downstream of the cut. Ribozyme cutting in the GluR-B intron 11 also strongly reduced the ratio of spliced/unspliced transcripts (Fig. 4c, right) , consistent with inhibition of splicing as we observed for the ribozyme in β-globin intron 2. 6) and derivatives with wild-type (WT) or mutant (Mut) hepatitis δ (δ) or hammerhead (ham) ribozymes inserted in intron 2 ( Supplementary Table 1 , plasmids 33 and 8-16). The HIV1 promoter (lanes 6-10) was activated by co-transfecting pSVTat. Lanes 11 and 12 show RPA of FN A2GA3 constructs with wild-type and mutant δ ribozymes in intron 2 ( Supplementary Table 1 a r t i c l e s
Exon cutting can inhibit splicing independent of exon definition
Communication across the last exon between the splicing and 3′ endprocessing proteins normally enhances removal of the last intron and cleavage at the poly(A) site. We addressed whether RNA continuity of the terminal exon is required for splicing of the last intron by incorporating the wild-type and mutant δ ribozymes at the EcoRI site in exon 3, 50 nt downstream of the 3′ splice site and 190 nt upstream of the poly(A) site. Severing exon 3 markedly inhibited intron 2 splicing, as assayed by RPA with a probe spanning the 5′ splice site (Fig. 5a, lanes 1-3) . We observed a similar effect on intron 2 splicing when we analyzed nuclear RNA, thereby eliminating the possibility of a bias introduced by selective RNA degradation in the cytoplasm (Supplementary Fig. 4, lanes 1 and 3) . The wild-type δ ribozyme in exon 3 also inhibited splicing to a cryptic 3′ splice site within intron 2 when the natural 3′ splice site was deleted (data not shown). Splicing of intron 2 was also strongly inhibited by the wild-type ribozyme in exon 3 when the fibronectin splicing enhancer was inserted 10 nt upstream of the ribozyme (Fig. 5a, lanes 6 and 7) . We conclude that the inhibition of intron 2 splicing by ribozyme cutting in exon 3 is not rescued by a splicing enhancer. If the ribozyme in exon 3 disrupts splicing by preventing exon definition, then it should have no effect when exon definition is prevented. To test this prediction, we blocked exon definition by inactivating the poly(A) site in constructs with the wild-type and mutant δ ribozyme in exon 3 (Fig. 5) . In these experiments, intron 2 splicing was stimulated by the fibronectin splicing enhancer upstream of the ribozyme. The wild-type ribozyme inhibited splicing about fivefold relative to the mutant, even when exon definition was prevented by mutating the poly(A) site (Fig. 5a, lanes 4 and 5) . A ribozyme situated downstream of exon 3, however, had little effect on splicing, presumably because, in this case, self-cleavage occurs mostly after commitment to splicing (Fig. 5a, lanes 8 and 9) .
Unexpectedly, splicing of intron 1 in total and nuclear RNA fractions monitored by RPA with a probe spanning the 3′ splice site was inhibited by ribozyme cutting in exon 3 to about the same extent as splicing of intron 2 ( Fig. 5b and Supplementary  Fig. 4) . Similar results were obtained with exon 3 ribozyme constructs with and without the fibronectin splicing enhancer (Fig. 5b) . In summary, ribozyme cleavage within exon 3 inhibited intron 1 splicing and intron 2 splicing even after inactivation of the poly(A) site. Neither of these effects is easily explained by disruption of exon definition. These results therefore suggest that another mechanism is responsible for aborting pre-mRNA processing when the nascent RNA is damaged by an endonuclease. Table 1 , plasmids [25] [26] [27] [28] [29] [30] [31] [32] [33] . The fibronectin splicing enhancer (FN) (lanes 6 and 7) does not rescue splicing that is inhibited by the wild-type ribozyme. Ribozyme cutting upstream of the mutant poly(A) site (lanes 4 and 5) has a greater effect on splicing than cutting downstream (lanes 8 and 9) . The map depicts antisense RPA probes, the positions of ribozymes either within exon 3 or 115 nt downstream, the fibronectin splicing enhancer, the poly(A) site and the A2GA3 mutation as in Figure 2 , with arrows defined as in Figure 1. (b) Inhibition of intron 1 splicing by ribozyme cutting in exon 3 with and without the fibronectin splicing enhancer. VA is a loading control ( Supplementary  Table 1 , plasmids 33, 25, 26, 29 and 30) . Supplementary Table 1 , plasmids 33, 25 and 26). (b) RPA of 5′ ends and transcripts that read around the plasmid. Read-around transcription indicates failure to terminate, which correlates with poor cleavage at the poly(A) site in A2GA3 mutants and with the wild-type δ ribozyme in exon 3 (lanes 2-4) (Supplementary Table 1, plasmids 33-34, 25 and 26) . Arrows in map are as defined in Figure 1 Inhibition of 3′ processing and termination by ribozyme cutting Ribozyme cutting of exon 3 specifically reduced the ratio of transcripts cleaved at the poly(A) site relative to uncleaved precursors, consistent with inhibition of 3′ end processing (Fig. 6a, lanes 1-3) . These results therefore suggest that cross-exon communication that enhances cleavage and polyadenylation is sensitive to disruption of RNA continuity within the last exon. If 3′ end processing is really aborted in response to ribozyme cleavage, then we predict there should be a defect in termination, which is normally tightly coupled to processing. Conversely, if 3′ end processing is not directly affected by ribozyme cleavage upstream of the poly(A) site, then termination should occur normally. We investigated whether ribozyme cleavage affects transcription termination by using RPA to quantify correctly initiated 5′ ends and read-around transcripts, which run all the way around the plasmid because they failed to terminate 41 . To validate this assay, we compared wild-type with the A2GA3 poly(A) site mutant and confirmed that the mutation greatly enhanced read-around transcription with and without the fibronectin splicing enhancer in exon 3 (Fig. 6b, lanes 1-3) . We note that, although termination in these experiments is dependent on the poly(A) site, it is independent of the co-transcriptional cleavage (CoTC) termination element 26, 42 , which is absent from our constructs. Ribozyme cutting in exon 3 strongly inhibited termination, relative to the mutant ribozyme control (Fig. 6b, lanes 4 and 5) . Similarly hepatitis δ, but not hammerhead, ribozyme cutting in intron 2 inhibited termination, as determined by the read-around transcription assay (Supplementary Fig. 5a ).
Overall, we found a strong correlation between the extent of cleavage at a wild-type poly(A) site and termination downstream, as predicted by the torpedo model for coupling of termination with 3′ end processing 41 . These results contrast with a previous report that hammerhead ribozyme cutting in exon 3 disrupted 3′ processing without affecting termination 26 ; however, 3′ end processing in this case was not assayed by quantifying cleaved and uncleaved transcripts. This apparent discrepancy may be due to slower cutting by the hammerhead ribozyme. The fact that ribozyme cleavage upstream of the poly(A) site prevents transcription termination shows that ribozyme cutting occurs before the transcript is released from the template. Notably, the inhibition of termination confirms that processing of a wild-type poly(A) site, which is coupled to termination, is disrupted by ribozyme cutting, presumably by preventing assembly of a functional 3′ end-processing complex.
DISCUSSION
Ribozyme disruption of splicing: implications for exon tethering
We report that a contiguous nascent RNA chain is necessary for processing by splicing and cleavage polyadenylation. Both of these co-transcriptional processing events are vulnerable to disruption by endonucleolyic damage to exons or introns. During transcription, exon definition and coupling between capping, splicing and 3′ end processing are facilitated by interactions between proximal and distal segments of the pre-mRNA. It was previously proposed that tethering of exons to Pol II enhances co-transcriptional processing because of the unexpected finding that a hammerhead ribozyme in β-globin intron 2 does not disrupt splicing 21, 43 . We found that, in contrast to cleavage by the hammerhead ribozyme, intron cleavage by the hepatitis δ ribozyme does impair splicing, as well as 3′ end processing and protein expression ( Figs. 3 and 4 and Supplementary Fig. 3) . Cleavage by δ ribozyme between the self-complementary sequences in exon 11 and intron 11 of GluR-B also prevent RNA editing by ADAR (Fig. 4c) . Therefore exon-intron base pairing seems to be prevented if the complementary sequences in the nascent RNA are separated by a ribozyme cut. These observations suggest that exons upstream of a ribozyme cut site dissociate from the TEC rather than being tethered to it. Consistent with this model, ribozyme cutting in β-globin exon 2 released the RNA 5′ end from the gene, as determined by ChIP of the CBC (Fig. 2b) .
The hepatitis δ ribozyme cuts about an order of magnitude faster than the minimal hammerhead ribozyme 37, 38 , and we suggest that splicing is disrupted only if an intronic ribozyme cuts fast enough to interfere with co-transcriptional spliceosome assembly. Intron cleavage by Drosha during miRNA excision probably does not disrupt splicing 23, 24 (Supplementary Fig. 2b) because, like the hammerhead ribozyme, Drosha is slow relative to spliceosome assembly. Kinetic competition between splicing and ribozyme cutting is also suggested by the observation that the hammerhead inserted in a yeast intron inhibited splicing only if transcription was slowed by mutation of elongation factors 22 .
Inhibition of processing upstream and downstream of a ribozyme
Processing is inhibited at positions upstream and downstream of a ribozyme cut site in the nascent pre-mRNA. Cutting within exons is predicted to inhibit splicing by disrupting exon definition 21, 27 , but our experiments show such an effect cannot completely account for the effects of exonic ribozymes. For example, intron 1 splicing was diminished by cutting exon 3, and intron 2 splicing was impaired by cutting exon 1 (Figs. 1b and 5b) . Furthermore, severing exon 3 disrupted splicing of intron 2, even when exon 3 definition was prevented by mutating the poly(A) site (Fig. 5a, lanes 4 and 5) .
We suggest that, in addition to effects on exon definition, two factors contribute to disruption of processing upstream and downstream of a ribozyme cut site: (i) separation of the TEC with its CTD-associated processing factors from sequences upstream of the cut (Fig. 6c) ; (ii) separation of CBC bound to the 5′ cap from sequences downstream of the cut (Fig. 2b) . For example, the inhibition of intron 1 splicing by cleavage in intron 2 or exon 3 (Figs. 4a and 5b and Supplementary Fig. 4, lanes 5 and 7) is most easily explained by release of the 5′ segment of the transcript from the TEC (Fig. 2b) , so that it is less accessible to processing factors associated with the CTD (Fig. 6c) . Conversely, inhibition of intron 2 splicing by cutting in exons 1 and 2 (Figs. 1b,c and Supplementary Fig. 1 ) is most easily explained by release of the RNA 5′ end (Fig. 2b) , because CBC stimulates splicing and cleavage and polyadenylation [15] [16] [17] [18] (Fig. 6c) . Similarly, 3′ end processing and coupled transcription termination were both inhibited by ribozyme cutting upstream in intron 2 or exon 3 (Fig. 6a,b and Supplementary Fig. 5a ).
In summary, these results show that damage inflicted in exons or introns causes processing events upstream and downstream of the cut site to be aborted. This conclusion is consistent with the model that the nascent transcript has an important function in stabilizing complexes between processing factors and the Pol II TEC 20, 34 and that damage to the RNA would therefore destabilize such complexes. This 'bail-out' mechanism would have the potential advantage of avoiding formation of nonproductive complexes between processing factors and Pol II that is not engaged in synthesis of a functional transcript.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
